Financial Contrast: LifeMD (LFMD) and Its Competitors

LifeMD (NASDAQ:LFMD – Get Free Report) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its peers? We will compare LifeMD to related businesses based on the strength of its earnings, analyst recommendations, valuation, profitability, dividends, institutional ownership and risk.

Profitability

This table compares LifeMD and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
LifeMD -0.25% -188.63% -32.24%
LifeMD Competitors -1.05% -139.10% -2.48%

Insider & Institutional Ownership

35.5% of LifeMD shares are held by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are held by institutional investors. 17.2% of LifeMD shares are held by company insiders. Comparatively, 14.9% of shares of all “Healthcare Providers & Services” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares LifeMD and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
LifeMD $194.05 million $14.35 million -26.58
LifeMD Competitors $21.12 billion $301.67 million -3.72

LifeMD’s peers have higher revenue and earnings than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a summary of recent ratings for LifeMD and its peers, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeMD 1 1 8 0 2.70
LifeMD Competitors 1886 7759 13421 836 2.55

LifeMD currently has a consensus price target of $6.71, suggesting a potential upside of 320.96%. As a group, “Healthcare Providers & Services” companies have a potential upside of 22.18%. Given LifeMD’s stronger consensus rating and higher probable upside, analysts clearly believe LifeMD is more favorable than its peers.

Volatility and Risk

LifeMD has a beta of 2.19, indicating that its share price is 119% more volatile than the S&P 500. Comparatively, LifeMD’s peers have a beta of 0.98, indicating that their average share price is 2% less volatile than the S&P 500.

Summary

LifeMD peers beat LifeMD on 7 of the 13 factors compared.

About LifeMD

(Get Free Report)

LifeMD, Inc. is a virtual healthcare company that connects patients with medical providers through its telehealth platform. Its services include virtual primary care and specialty care, with offerings in areas such as men’s health and weight management. The company operates the LifeMD and Rex MD brands and supports care through online consultations, treatment plans and, when prescribed, medication. Service availability and treatment options may vary by state and individual patient needs. LifeMD serves patients in the United States.

Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.com's FREE daily email newsletter.